| Code | 2425D | ||||||||||
| MA number | 23/0240/05-S | ||||||||||
| Product Form: | sup 3 (strip Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Karo Pharma AB, Sweden | ||||||||||
| Therapeutic Class: | 23 - ANTIHAEMORRHOIDALIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | strip Al/Al | ||||||||||
| Route of admin.: | Rectal use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10b fixed combination application |
| MA issued: | 19.08.2005 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Doloproct_sup_08.2020.doc
|
| PIL: |
PIL_Doloproct 1 mg + 40 mg čapíky_12.2021.pdf
|
| Safety feature | Yes |
| Data update: | 12.09.2019 |
